Literature DB >> 15969742

Astrocyte- and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures.

Sunita Gopalan1, Aneta Kasza, Weili Xu, Daniel L Kiss, Katarzyna M Wilczynska, Russell E Rydel, Tomasz Kordula.   

Abstract

The distal serpin subcluster contains genes encoding alpha1-antichymotrypsin (ACT), protein C inhibitor (PCI), kallistatin (KAL) and the KAL-like protein, which are expressed in hepatocytes, but only the act gene is expressed in astrocytes. We show here that the tissue-specific expression of these genes associates with astrocyte- and hepatocyte-specific chromatin structures. In hepatocytes, we identified 12 Dnase I-hypersensitive sites (DHSs) that were distributed throughout the entire subcluster, with the promoters of expressed genes accessible to restriction enzyme digestion. In astrocytes, only six DHSs were located exclusively in the 5' flanking region of the act gene, with its promoter also accessible to restriction enzyme digestion. The acetylation of histone H3 and H4 was found throughout the subcluster in both cell types but this acetylation did not correlate with the expression pattern of these serpin genes. Analysis of histone modifications at the promoters of the act and pci genes revealed that methylation of histone H3 on lysine 4 correlated with their expression pattern in both cell types. In addition, inhibition of methyltransferase activity resulted in suppression of ACT and PCI mRNA expression. We propose that lysine 4 methylation of histone H3 correlates with the tissue-specific expression pattern of these serpin genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969742      PMCID: PMC4557805          DOI: 10.1111/j.1471-4159.2005.03204.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  42 in total

1.  Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci.

Authors:  M D Litt; M Simpson; F Recillas-Targa; M N Prioleau; G Felsenfeld
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

2.  Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity.

Authors:  Huck Hui Ng; François Robert; Richard A Young; Kevin Struhl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

Authors:  J M Pasternack; C R Abraham; B J Van Dyke; H Potter; S G Younkin
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements.

Authors:  A M Delegeane; L H Ferland; P L Mellon
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

Review 5.  Nuclease hypersensitive sites in chromatin.

Authors:  D S Gross; W T Garrard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

6.  Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.

Authors:  T Kordula; R E Rydel; E F Brigham; F Horn; P C Heinrich; J Travis
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

7.  CCAAT/enhancer-binding protein alpha alters histone H3 acetylation at large subnuclear domains.

Authors:  W H Zhang; R Srihari; R N Day; F Schaufele
Journal:  J Biol Chem       Date:  2001-09-21       Impact factor: 5.157

8.  The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1.

Authors:  P Rollini; R E Fournier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Histone H3 lysine 4 methylation patterns in higher eukaryotic genes.

Authors:  Robert Schneider; Andrew J Bannister; Fiona A Myers; Alan W Thorne; Colyn Crane-Robinson; Tony Kouzarides
Journal:  Nat Cell Biol       Date:  2003-12-07       Impact factor: 28.824

10.  Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.

Authors:  P E Fraser; J T Nguyen; D R McLachlan; C R Abraham; D A Kirschner
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

View more
  5 in total

1.  Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Authors:  Cao Chen; Xiao-Feng Xu; Ren-Qing Zhang; Yue Ma; Yan Lv; Jian-Le Li; Qiang Shi; Kang Xiao; Jing Sun; Xiao-Dong Yang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

2.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

3.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

4.  EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Steven W Paugh; Lauren Bryan; Dmitri Kapitonov; Katarzyna M Wilczynska; Sunita M Gopalan; Hanna Rokita; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  FASEB J       Date:  2007-09-12       Impact factor: 5.191

5.  Alzheimer's Amyloidopathy: An Alternative Aspect.

Authors:  Björn Regland; Andrew McCaddon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.